Covered recipient · General Payments record
JENNIFER N BROWN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,351.60
- Reported across 76 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $334.55 | 14 |
| Consulting Fee | $280.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $323.51 | 3 |
| ABBVIE INC. | $132.66 | 5 |
| EISAI INC. | $50.24 | 2 |
| BAXTER HEALTHCARE | $32.35 | 1 |
| Hologic Sales and Service, LLC | $25.22 | 1 |
| Aspira Women's Health Inc | $17.86 | 1 |
| Myriad Genetic Laboratories, Inc. | $16.48 | 1 |
| GlaxoSmithKline, LLC. | $16.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $50.21 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106833656 | CMS |
| ABBVIE INC. | $11.11 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106833658 | CMS |
| ABBVIE INC. | $26.38 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106833660 | CMS |
| ABBVIE INC. | $11.59 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106833662 | CMS |
| ABBVIE INC. | $33.37 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106833664 | CMS |
| Aspira Women's Health Inc | $17.86 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126782110 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.67 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105789200 | CMS |
| AstraZeneca Pharmaceuticals LP | $280.00 | 09/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104301022 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.84 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104240017 | CMS |
| Baxter Healthcare | $32.35 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120662379 | CMS |
| Eisai Inc. | $23.87 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110805240 | CMS |
| Eisai Inc. | $26.37 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110805238 | CMS |
| GlaxoSmithKline, LLC. | $16.23 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115960461 | CMS |
| Hologic Sales and Service, LLC | $25.22 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084879147 | CMS |
| Myriad Genetic Laboratories, Inc. | $16.48 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152544454 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.